RecruitingPhase 2NCT07652879
Rare condition
POEMS syndrome
7
studies recruiting now
as of 7 Sept 2026
18
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
17 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07448935
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
RecruitingNCT06252948
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
RecruitingNCT03717844
Registry for Adults With Plasma Cell Disorders (PCD's)
RecruitingNCT06040567
Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 7 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new POEMS syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About POEMS syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Daratumumab (Daratumumab component of darzalex faspro)
Phase 2Dexamethasone (Aeroseb-dex)
Phase 2Lenalidomide (Lenalidomide accord)
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).